FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895850826> ?p ?o ?g. }

• W2895850826 endingPage "1139" @default.
• W2895850826 startingPage "1131" @default.
• W2895850826 abstract "Palmer amaranth (Amaranthus palmeri S. Wats) is one of the most common and troublesome weeds in the USA. Palmer amaranth resistance to acetolactate synthase (ALS) inhibitors is widespread in the USA, as in Arkansas. The cross-resistance patterns and mechanism of resistance are not known. Experiments were conducted to determine cross-resistance to ALS inhibitors and identify target-site mutations in 20 Palmer amaranth localities from 13 counties in Arkansas.All Palmer amaranth localities tested had plants cross-resistant to imazethapyr, flumetsulam, primisulfuron, pyrithiobac and trifloxysulfuron. The dose of trifloxysulfuron that caused 50% control was 21-56-fold greater for resistant accessions than for susceptible ones. All but three resistant plants analyzed had one or two relative copies of ALS; one plant had seven relative copies. All resistant plants tested (18 localities) carried the Trp574Leu mutation, which is known to confer broad resistance to ALS inhibitors, supporting the cross-resistance pattern observed. Besides the Trp574Leu mutation, 30% of localities had individuals with one additional resistance-conferring mutation including Ala122Thr, Pro197Ala or Ser653Asn.The Trp574Leu mutation in ALS is the primary mechanism of resistance to ALS inhibitors in Palmer amaranth from Arkansas, USA. In some localities, multiple mutations have accumulated in one plant. All localities tested contained plants with resistance to five families of ALS inhibitors. Localities with extremely high resistance to ALS inhibitors, and those outside the subset we studied, may harbor non-target site resistance mechanisms. ALS inhibitors are generally no longer effective on Palmer amaranth in these localities from the US mid-south. © 2018 Society of Chemical Industry." @default.
• W2895850826 created "2018-10-26" @default.
• W2895850826 creator A5030804351 @default.
• W2895850826 creator A5036472874 @default.
• W2895850826 creator A5039691118 @default.
• W2895850826 creator A5061291324 @default.
• W2895850826 creator A5065633602 @default.
• W2895850826 creator A5081632776 @default.
• W2895850826 date "2018-12-10" @default.
• W2895850826 modified "2023-10-14" @default.
• W2895850826 title "Target‐site mutation accumulation among ALS inhibitor‐resistant Palmer amaranth" @default.
• W2895850826 cites W147335075 @default.
• W2895850826 cites W1510497395 @default.
• W2895850826 cites W1586549738 @default.
• W2895850826 cites W1985819727 @default.
• W2895850826 cites W1986742054 @default.
• W2895850826 cites W1996944719 @default.
• W2895850826 cites W2003562945 @default.
• W2895850826 cites W2022305509 @default.
• W2895850826 cites W2024126729 @default.
• W2895850826 cites W2029814483 @default.
• W2895850826 cites W2033719620 @default.
• W2895850826 cites W2043497670 @default.
• W2895850826 cites W2070479168 @default.
• W2895850826 cites W2081485857 @default.
• W2895850826 cites W2084367121 @default.
• W2895850826 cites W2107373833 @default.
• W2895850826 cites W2135246588 @default.
• W2895850826 cites W2141972322 @default.
• W2895850826 cites W2144468096 @default.
• W2895850826 cites W2146040475 @default.
• W2895850826 cites W2146859833 @default.
• W2895850826 cites W2167017368 @default.
• W2895850826 cites W2168038523 @default.
• W2895850826 cites W2178259921 @default.
• W2895850826 cites W2300355794 @default.
• W2895850826 cites W2338354004 @default.
• W2895850826 cites W2339487831 @default.
• W2895850826 cites W2464774981 @default.
• W2895850826 cites W2465960432 @default.
• W2895850826 cites W2467046873 @default.
• W2895850826 cites W2469495743 @default.
• W2895850826 cites W2507338414 @default.
• W2895850826 cites W2512536755 @default.
• W2895850826 cites W2531205096 @default.
• W2895850826 cites W2598325279 @default.
• W2895850826 cites W2615164253 @default.
• W2895850826 cites W2734589198 @default.
• W2895850826 cites W2756315211 @default.
• W2895850826 cites W2793518478 @default.
• W2895850826 doi "https://doi.org/10.1002/ps.5232" @default.
• W2895850826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30298618" @default.
• W2895850826 hasPublicationYear "2018" @default.
• W2895850826 type Work @default.
• W2895850826 sameAs 2895850826 @default.
• W2895850826 citedByCount "16" @default.
• W2895850826 countsByYear W28958508262019 @default.
• W2895850826 countsByYear W28958508262020 @default.
• W2895850826 countsByYear W28958508262021 @default.
• W2895850826 countsByYear W28958508262022 @default.
• W2895850826 countsByYear W28958508262023 @default.
• W2895850826 crossrefType "journal-article" @default.
• W2895850826 hasAuthorship W2895850826A5030804351 @default.
• W2895850826 hasAuthorship W2895850826A5036472874 @default.
• W2895850826 hasAuthorship W2895850826A5039691118 @default.
• W2895850826 hasAuthorship W2895850826A5061291324 @default.
• W2895850826 hasAuthorship W2895850826A5065633602 @default.
• W2895850826 hasAuthorship W2895850826A5081632776 @default.
• W2895850826 hasConcept C104317684 @default.
• W2895850826 hasConcept C156719811 @default.
• W2895850826 hasConcept C182707283 @default.
• W2895850826 hasConcept C2775891814 @default.
• W2895850826 hasConcept C2778080818 @default.
• W2895850826 hasConcept C2780785311 @default.
• W2895850826 hasConcept C2781052702 @default.
• W2895850826 hasConcept C49105822 @default.
• W2895850826 hasConcept C501734568 @default.
• W2895850826 hasConcept C54355233 @default.
• W2895850826 hasConcept C57473165 @default.
• W2895850826 hasConcept C59822182 @default.
• W2895850826 hasConcept C6557445 @default.
• W2895850826 hasConcept C86803240 @default.
• W2895850826 hasConceptScore W2895850826C104317684 @default.
• W2895850826 hasConceptScore W2895850826C156719811 @default.
• W2895850826 hasConceptScore W2895850826C182707283 @default.
• W2895850826 hasConceptScore W2895850826C2775891814 @default.
• W2895850826 hasConceptScore W2895850826C2778080818 @default.
• W2895850826 hasConceptScore W2895850826C2780785311 @default.
• W2895850826 hasConceptScore W2895850826C2781052702 @default.
• W2895850826 hasConceptScore W2895850826C49105822 @default.
• W2895850826 hasConceptScore W2895850826C501734568 @default.
• W2895850826 hasConceptScore W2895850826C54355233 @default.
• W2895850826 hasConceptScore W2895850826C57473165 @default.
• W2895850826 hasConceptScore W2895850826C59822182 @default.
• W2895850826 hasConceptScore W2895850826C6557445 @default.
• W2895850826 hasConceptScore W2895850826C86803240 @default.
• W2895850826 hasFunder F4320309836 @default.
• W2895850826 hasIssue "4" @default.

• next